Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Recent News

Wednesday 11 March, 2015

11-Mar-2015 03:11 PM

CMA considers Greene King-Spirit Pub deal

The Competition and Markets Authority is looking at the anticipated acquisition by Greene King of Spirit Pub Co. The CMA is considering whether this transaction if carried into effect, will result in the creation of a relevant merger situation under the
11-Mar-2015 03:06 PM

Source BioScience schedules FY results

Source BioScience, the international laboratory services and products business, will be announcing its preliminary results for the year ended 31 December on 25 March. At 3:06pm: (LON:SBS) Source BioScience PLC share price was 0p at 12.25p Story provi
11-Mar-2015 03:02 PM

Medigene net losses narrow

Medigene's total revenue rose by 82% to �?¬13.8m in the 2014. Revenue from the marketed drug Veregen increased by 23% to �?¬5.2m. Other operating income includes EUR 2.7 m for a milestone achieved at the end of 2014 for the partnered drug c
11-Mar-2015 03:02 PM

Market Movers - Top risers and fallers between 14:00 and 15:00

Overall Market Mercom Oil Sands 5.13 +10.80% Clontarf Energy Ord 0.25p 0.38 +8.57% Avocet Mining 5.51 +7.62% Flying Brands 2.03
11-Mar-2015 03:00 PM

Market Movers - Top risers and fallers at 15:00

FTSE 100 Aggreko 1567.00 +3.43% Royal Mail 430.30 +1.87% International Consolidated Airlines 554.75 +1.70% GKN 357.25 +1.
11-Mar-2015 02:49 PM

Playworld opens London office

Playworld, a leading playground equipment and surfacing manufacturer committed to saving outdoor unstructured play, has announced the opening of a London office. The company established the division to better service customers in England, Scotland and Wal
11-Mar-2015 02:28 PM

Macromac unit agrees sale of warehouse

Macromac's wholly owned operating subsidiary, Macromac Technology, has agreed the sale of a warehouse at No 16, Jalan Serendah 26/39, i-Parc2, Section 26, 40400 Shah Alam, Selangor Darul Ehsan for RM4.15m. The purchaser is Polyscientific Enterprise
11-Mar-2015 02:13 PM

European Wealth non-exec steps down

European Wealth non-executive director Paul Everitt has stepped down with immediate effect. The board thanked him for his significant contribution to the company over the past several years and wished him well for the future. At 2:13pm: (LON:EWG) Euro
11-Mar-2015 02:10 PM

Gamma Communications schedules FY results

Gamma Communications, a leading, technology based provider of communications services to the UK business market, will publish its audited results for the year ended 31 December on 20 March. At 2:10pm: (LON:GAMA) Gamma Communications Plc Ord 0.25p share
11-Mar-2015 02:02 PM

Market Movers - Top risers and fallers between 13:00 and 14:00

Overall Market Xtract Energy 0.10 +11.11% Transense Technologies 1.38 +10.40% Noricum Gold 0.23 +9.52% Stellar Resources Ord 0.01p 0.38
11-Mar-2015 02:00 PM

Market Movers - Top risers and fallers at 14:00

FTSE 100 Aggreko 1566.00 +3.37% Royal Mail 431.70 +2.20% CRH 1727.00 +1.65% Burberry Group 1842.00 +1.
11-Mar-2015 01:52 PM

Grupo Clar�­n net sales up

Grupo Clar�­n's net sales rose by 39.1% to Ps.19,616.2m in the year to the end of December. Adjusted earnings before interest, tax, depreciation and amortisation increased by 53.5% to Ps.5,024.5m while margins increased to 25.6% - up from 23.2%
11-Mar-2015 01:46 PM

CMA revokes initial enforcement order

The Competition and Markets Authority has made a revocation order under section 72(4) of the Enterprise Act 2002 in relation to the completed acquisition by Ticketmaster Europe Holdco Limited of Seatwave. This order revokes the initial enforcement order
11-Mar-2015 01:39 PM

CMA revokes enforcement order

The Competition and Markets Authority has made a revocation order under section 72(4) of the Enterprise Act 2002 in relation to the completed acquisition by Healthcare Environmental (Group) Limited of G.W. Butler Limited. This order revokes the initial
11-Mar-2015 01:02 PM

Market Movers - Top risers and fallers between 12:00 and 13:00

Overall Market Doriemus Ord 0.001p 0.10 +25.00% PeerTV 0.98 +18.07% Gate Ventures 17.00 +17.24% Alba Mineral Resources 0.38
11-Mar-2015 01:00 PM

Market Movers - Top risers and fallers at 13:00

FTSE 100 Aggreko 1554.00 +2.57% CRH 1729.00 +1.77% Royal Mail 428.55 +1.46% Mondi 1327.50 +1.
11-Mar-2015 12:51 PM

Brokers' round-up, Cairn Energy in focus

Jefferies International cuts Cairn Energy to hold from buy, target cut from 220p to 172p. JP Morgan Cazenove reiterates overweight on Cairn Energy, target cut from 227p to 206p. Investec reiterates buy on Cairn Energy, target cut from 225p to 185p. Jef
11-Mar-2015 12:02 PM

Market Movers - Top risers and fallers between 11:00 and 12:00

Overall Market PeerTV 0.85 +32.81% Alecto Minerals 0.18 +28.57% Inspirit Energy Holdings (formerly 0.67 +15.52% Anglo Asian Mining 7.00
11-Mar-2015 12:00 PM

Market Movers - Top risers and fallers at 12:00

FTSE 100 Burberry Group 1853.00 +2.04% Aggreko 1543.00 +1.85% GKN 356.65 +1.32% Mondi 1325.50 +1.
11-Mar-2015 11:36 AM

Ormonde Mining confirms Almonty approach

Ormonde Mining has confirmed, as announced by Almonty Industries, that it last night received an unsolicited indicative non-binding proposal with respect to a potential offer for Ormonde. The proposal from Almonty, which does not include any material det
11-Mar-2015 11:33 AM

LRM's revenue

Lombard Risk Management (AIM: LRM), a leading global provider of collateral management, liquidity and regulatory reporting and compliance solutions for the financial services industry, has reported that revenues for the year ending March 31 2015 will fall
11-Mar-2015 11:02 AM

Market Movers - Top risers and fallers between 10:00 and 11:00

Overall Market Sefton Resources Inc 0.09 +12.50% Ormonde Mining 3.75 +10.95% Tengri Resources Ord 5p (di) 3.50 +7.69% PeerTV 0.64
11-Mar-2015 11:00 AM

Market Movers - Top risers and fallers at 11:00

FTSE 100 Mondi 1334.50 +1.95% Aggreko 1539.50 +1.62% Burberry Group 1845.00 +1.60% Capita Group (The) 1171.50 +1.
11-Mar-2015 10:02 AM

Market Movers - Top risers and fallers between 09:00 and 10:00

Overall Market Surgical Innovations Group 1.53 +22.40% Alternative Energy 0.08 +14.29% Action Hotels 61.50 +8.85% Northcote Energy Limited 0.13
11-Mar-2015 10:00 AM

Clinigen extends Foscavir US distribution contract

Clinigen Group has extended the exclusive licensing and distribution agreement for the anti-viral product Foscavir (foscarnet sodium) in the US with Hospira. The original distribution agreement with Hospira established in July 2011 was due to expire in

a d v e r t i s e m e n t